Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is considered one of the deadliest tumors worldwide. The diagnosis is often possible only in the latter stages of the disease, with patients already presenting an advanced or metastatic tumor. It is also one of the cancers with poorest prognosis, presenting a...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2021-03-01
|
| Sarja: | Pharmaceuticals |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/1424-8247/14/3/280 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|